Pure Global
NCT06363071

APA and PAS Training for Gait Initiation in Parkinson's Disease

Gait-initiation Related APA Training in Individuals With Parkinson Disease -Explicit Training and Paired Associative Stimulation(PAS) Priming
Chang Gung University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Parkinson Disease
Drug/Device/Intervention
Weight shift training and APA feedback
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Chang Gung University
Location
Taoyuan, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Jun 13, 2022
End date
May 31, 2025
Enrollment
100 participants
Primary outcome

Balance Performance,COP Path Length in Balance Tasks,COP Displacement in Balance Tasks,Motor Evoked Potentials (MEPs),Intracortical Facilitation (ICF),Intracortical Inhibition (ICI),Walking Speed,Step Length,Step Time

Summary

Our research focused on understanding the interplay between brain excitability and balance
 function in patients with Parkinson's disease (PD), alongside evaluating effective physical
 therapy methods. It highlights the prevalence of non-motor disorders and cognitive
 impairments among PD patients, including balance and postural issues, cognitive function
 decline, and gait instability. Additionally, it notes that PD patients exhibit abnormal
 electrophysiological responses, indicating altered central excitability.

ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismSecondary parkinsonism, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06363071
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06363071 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung University and is currently Recruiting. The study focuses on Parkinson Disease. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.